【レポートの概要（一部）】
1 Introduction (Page No. – 25)
1.1 Objectives of Study
1.2 Nuclear Medicine Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders
2 Research Methodology (Page No. – 29)
2.1 Research Methodology Steps
2.1.1 Research Design
2.1.2 Secondary and Primary Research Methodology
2.1.2.1 Secondary Research
2.1.2.2 Primary Research
2.1.2.3 Key Industry Insights
2.1.3 Key Data From Primary Sources
2.1.4 Key Insights From Primary Sources
2.1.5 Market Size Estimation Methodology
2.1.6 Market Data Validation and Triangulation
2.1.7 Assumptions for the Study
3 Executive Summary (Page No. – 38)
3.1 Introduction
3.2 Conclusion
4 Premium Insights (Page No. – 41)
4.1 Nuclear Medicine/Radiopharmaceuticals: Market Overview
4.2 Geographic Analysis: Nuclear Medicine Market, By PET Application (2016)
4.3 Nuclear Medicine Market, By Type (2016 vs 2021)
4.4 Geographical Snapshot of the Nuclear Medicine Market
5 Market Overview (Page No. – 44)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Investments Through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
5.2.1.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
5.2.1.3 Advances in Radiotracers
5.2.1.4 Increasing Incidence and Prevalence of Cancer and Cardiac Ailments
5.2.2 Restraints
5.2.2.1 Shorter Half-Life of Radiopharmaceuticals
5.2.2.2 High Cost of Nuclear Medicine Equipment
5.2.3 Opportunities
5.2.3.1 High Demand in Emerging Markets
5.2.3.2 Upcoming Radioisotopes
5.2.3.3 Use of Radiopharmaceuticals in Neurological Applications
5.2.4 Challenges
5.2.4.1 Shutdown of Nuclear Reactors
6 Nuclear Medicine Market, By Type (Page No. – 50)
6.1 Introduction
6.2 Diagnostic Nuclear Medicine/Radiopharmaceuticals
6.2.1 SPECT Radiopharmaceuticals
6.2.1.1 Technetium-99m
6.2.1.2 Thallium-201
6.2.1.3 Gallium-67
6.2.1.4 Iodine-123
6.2.1.5 Other SPECT Isotopes
6.2.2 PET Radiopharmaceuticals
6.2.2.1 Fluorine-18
6.2.2.2 Rubidium-82
6.2.2.3 Other PET Isotopes
6.3 Therapeutic Nuclear Medicine/Radiopharmaceuticals
6.3.1 Beta Emitters
6.3.1.1 Iodine-131
6.3.1.2 Yttrium-90
6.3.1.3 Samarium-153
6.3.1.4 Rhenium-186
6.3.1.5 Lutetium-177
6.3.1.6 Other Beta Emitters
6.3.2 Alpha Emitters
6.3.2.1 Radium-223
6.3.3 Brachytherapy Isotopes
6.3.3.1 Iodine-125
6.3.3.2 Iridium-192
6.3.3.3 Palladium-103
6.3.3.4 Cesium-131
6.3.3.5 Other Brachytherapy Isotopes
7 Nuclear Medicine Market, By Application (Page No. – 99)
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 SPECT Applications
7.2.1.1 Cardiology
7.2.1.2 Neurology
7.2.1.3 Thyroid
7.2.1.4 Other SPECT Applications
7.2.2 PET Applications
7.2.2.1 Oncology
7.2.2.2 Cardiology
7.2.2.3 Neurology
7.2.2.4 Other PET Applications
7.3 Therapeutic Applications
7.3.1 Thyroid
7.3.2 Bone Metastasis
7.3.3 Lymphoma
7.3.4 Endocrine Tumors
7.3.5 Other Therapeutic Applications
8 Nuclear Medicine Market, By Procedural Volume (Page No. – 130)
8.1 Introduction
8.2 Diagnostic Procedures
8.2.1 SPECT Radiopharmaceuticals
8.2.2 PET Radiopharmaceuticals
8.3 Therapeutic Procedures
8.3.1 Beta Emitters
8.3.2 Alpha Emitters
8.3.3 Brachytherapy Isotopes
9 Global Nuclear Medicine Market, By Region (Page No. – 140)
9.1 Introduction
9.2 Diagnostics
9.2.1 North America
9.2.2 U.S.
9.2.2.1 Domestic Production of Mo-99 in the U.S.
9.2.2.2 Approval of New Radiopharmaceuticals By the FDA
9.2.3 Canada
9.2.3.1 Extension of Operations at the Canadian National Research Universal (NRU) Reactor
9.2.3.2 Alternative Medical Isotope Technologies in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 New Irradiation Facility in Germany
9.3.2 France
9.3.2.1 Shutdown of the French Osiris Nuclear Reactor
9.3.3 U.K.
9.3.3.1 Increasing Adoption of Nuclear Medicine Equipment
9.3.4 Italy
9.3.4.1 Steady Growth in Healthcare Expenditure
9.3.5 Spain
9.3.5.1 Role of the Semnim in Spain
9.3.6 Rest of Europe (RoE)
9.3.6.1 Rapid Rise in the Geriatric Population
9.4 Asia-Pacific
9.4.1 Installations of PET Scanners in India
9.4.2 Investments By the Australian Government
9.4.3 Initiatives to Promote Health
9.5 Rest of the World
9.5.1 Iaea Initiatives in Latam
9.5.2 Argentina’s Increasing Irradiation Capacity
10 Global Nuclear Medicine Market, By Region (Page No. – 185)
10.1 Therapeutic Nuclear Medicine Market
10.1.1 North America
10.1.2 U.S.
10.1.2.1 FDA Approval for Alpha Emitters
10.1.2.2 Therapeutic Nuclear Medicine – Alternative Treatment Choice in Oncology
10.1.3 Canada
10.1.3.1 Expertise in Isotope Production
10.1.3.2 Government Initiatives to Increase the Number of Nuclear Medicine Treatment Centers
10.1.4 Europe
10.1.5 Germany
10.1.5.1 Radionuklidtherapeutika — A Research Program Conducted in Germany
10.1.6 France
10.1.6.1 the Firm Project
10.1.7 U.K.
10.1.7.1 “A Voice for Radiotherapy” Initiative in the U.K.
10.1.8 Italy
10.1.8.1 Growing Incidences of Cancer
10.1.9 Spain
10.1.9.1 Rising Demand for Radiotherapeutics
10.1.10 RoE
10.1.10.1 Government and Public–Private Investments
10.1.10.2 Research on Cancer in Poland
10.1.11 Asia-Pacific
10.1.11.1 Increasing Aging Population in Japan
10.1.11.2 Aging Population and Increasing Cancer Prevalence in China
10.1.11.3 Approval of Radium (223ra) Dichloride By the Therapeutic Goods Administration (TGA) in Australia
10.1.12 Rest of the World (RoW)
10.1.12.1 Increase in Cancer Incidences
11 Competitive Landscape (Page No. – 222)
11.1 Overview
11.2 Market Share Analysis
11.2.1 Introduction
11.2.2 Cardinal Health, Inc.
11.2.3 Mallinckrodt PLC
11.2.4 GE Healthcare
11.2.5 Bayer Healthcare
11.2.6 Lantheus Medical Imaging, Inc.
11.3 Competitive Situations and Trends
11.3.1 Agreements, Partnerships, and Contracts
11.3.2 Marketing and Promotional Activities
11.3.3 Expansions
11.3.4 Acquisitions
11.3.5 Product Approvals
11.3.6 Divestments
11.3.7 Product Launches
11.3.8 Other Strategies
12 Company Profiles (Page No. – 236)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 Cardinal Health, Inc.
12.3 Mallinckrodt PLC
12.4 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
12.5 Lantheus Medical Imaging, Inc.
12.6 Bayer AG
12.7 Bracco Imaging S.P.A
12.8 Eczacibasi-Monrol Nuclear Products
12.9 Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
12.10 Advanced Accelerator Applications S.A.
12.11 IBA Molecular
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 263)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.3.1 Cardinal Health, Inc.
13.3.2 Mallinckrodt PLC
13.3.3 GE Healthcare
13.3.4 Lantheus Medical Imaging, Inc.
13.3.5 Bayer AG
13.3.6 Bracco Imaging S.P.A
13.3.7 Eczacibasi-Monrol Nuclear Products
13.3.8 Nordion, Inc.
13.3.9 Advanced Accelerator Applications S.A.
13.3.10 IBA Molecular
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
【レポート販売概要】
■ タイトル：核医学/放射性医薬品の世界市場予測：診断（SPECT、PET）、治療（ベータ放射体、アルファ放射体、小線源療法アイソトープ）■ 英文：Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021
■ 発行日：2016年10月25日
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-PH-3590
■ 調査対象地域：グローバル
- 世界の塩市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of salt, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing salt production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: salt production in th …
- 世界のナノ触媒市場2015The Global Nanocatalysts Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Nanocatalysts industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Nanocatalysts market analysis is provided for the international markets including development trends, competit …
- 上肢義足の世界市場展望2017-20276According to Stratistics MRC, the Global Upper Limb Prosthetics Market is accounted for $214.8 million in 2017 and is expected to reach $322.6 million by 2026 growing at a CAGR of 4.6% during the forecast period. Increasing rate of cancer, trauma cases (road accidents), bone infection or disease and genetic disorders across the world are fuelling the market growth. However, inaccessibility of high …
- 団体旅行のアジア太平洋市場：レジャー団体、特別利益団体、ハイエンド団体、インセンティブ旅行The Asia-Pacific group travel market size is expected to be valued at $ 689.5 billion by 2030, registering a CAGR of 6.0% from 2019 to 2030. According to UNWTO, Tourism is a social, cultural, and economic phenomenon, which entails movement of people across countries or places outside their usual environment for personal or professional purpose. Tourism sector has grown uninterrupted over the past …
- キラル分離クロマトグラフィー用カラムの世界市場The global chiral separation chromatography columns market is estimated to grow at a CAGR of 5.2% from 2014 to 2019. Though the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the chiral separation chromatography columns, the Asia-Pacific region is expected to grow at the highest CAGR of 6.3% in the forecast period. The growth of the chiral separation chromatography …
- 缶詰食品の世界市場2016-2020About Canned Food Canned food products refer to food items that are processed, preserved, and packed into airtight metal containers. Canned food products find high demand globally because they require less time to cook, less storage space, and have a longer shelf life than fresh food. With consumer lifestyles becoming increasingly work-oriented and, consequently, hectic, people have less time to c …
- Opicapone (パーキンソン病)：医薬品市場予測及び分析（～2022）Opicapone (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. …
- 不眠症治療薬の世界市場予測および分析PharmaPoint: Insomnia - Global Drug Forecast and Market Analysis to 2023 Summary Insomnia is the most common sleep disorder and is believed to affect approximately 35% of the global population. The condition can be defined as patient-reported difficultly with sleep initiation or sleep maintenance which can include frequent awakenings, difficulty returning to sleep after awakenings, or awakening to …
- 術中医用画像撮影の世界市場：iCT、術中超音波、iMRI、CアームシステムThe global intraoperative imaging market is expected to reach USD 4.2 billion by 2025, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgeries is a major factor projected to propel growth during the forecast period. The popularity of minimally invasive surgery is rising because it is does not require major incisions, which results in reduced scarring, …
- Evolocumab（ACS/急性冠症候群）：医薬品市場予測及び分析（～2023）Evolocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Evolocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of whic …
- 心不全（心臓まひ）の疫学的予測EpiCast Report: Heart Failure - Epidemiology Forecast to 2025 Summary Heart Failure (HF), also referred to as congestive cardiac failure, is a heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic needs of the body. Eventually, without the heart's pumping action to deliver oxygen and nutrient-rich blood to the cells, fatigue, shortness of breath, a …
- スマートフォン用パワーマネジメントICの世界市場2018-2022110 pages, November 2018 About this market 5G network enhances the performance of smartphones by providing ultra-fast Internet connectivity with low latency and allowing faster data streaming. However, this enhanced performance results in high power consumption and thereby battery drainage. Advanced PMICs are being used in 5G phones to get optimal battery performance. Several governments are takin …
- ブルドーザーの世界市場2014-2018About Bulldozer A bulldozer is a type of crawler with an attached blade used to push and move soil, sand, rubble, or other such materials that create an obstruction during construction. The blade is typically equipped on rear-end with a ripper shaped as a claw that helps in loosening densely compacted materials. Various types of bulldozers operate in almost all types of infrastructure-related acti …
- 世界の石油・ガスビジネス・コンフィデンス・レポート（2013年4Q）Why was the report written? This report is the result of an extensive survey drawn from Kable’s exclusive panel of leading global oil and gas industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the oil and gas industry, and forecasts company and industry growth prospects over the next six months. Furthermore, it also provides informa …
- インフルエンザ診断の世界市場分析：タイプ別（急性インフルエンザ診断試験[RIDT]、逆転写ポリメラーゼ連鎖反応[RT-PCR]、細胞培養、その他 – 免疫蛍光、血清学）、エンドユーザー別（病院、研究所、POCT）、セグメント予測The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater …
